FDA.reportPublic FDA data

50 ML ramucirumab 10 MG/ML Injection [Cyramza]

RxCUI
1657781
RxNorm name
50 ML ramucirumab 10 MG/ML Injection [Cyramza]
Display name
50 ML ramucirumab 10 MG/ML Injection [Cyramza]
Full name
50 ML ramucirumab 10 MG/ML Injection [Cyramza]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:20

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125477Cyramzaramucirumab351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CYRAMZARAMUCIRUMABEli Lilly and Companyc6080942-dee6-423e-b688-1272c2ae90d42026-06-09Warnings, Adverse reactionsExact identifier
rxcui: 1657781

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
c6080942-dee6-423e-b688-1272c2ae90d4Cyramza 500 MG in 50 ML Injection [PSN] · 50 ML ramucirumab 10 MG/ML Injection [Cyramza] [SBD] · Cyramza 500 MG per 50 ML Injection [SY]347These highlights do not include all the information needed to use CYRAMZA safely and effectively. See full prescribing information for CYRAMZA. CYRAMZA (ramucirumab) injection, for intravenous use Initial U.S. Approval: 201420251218